Authors : Ravindra J Shinde, Sushama Dugad, Gauri Kulkarni, Kappagantu Surya Chaitanya Neeladrirao Subbarao
DOI : 10.18231/j.pjms.2022.049
Volume : 12
Issue : 2
Year : 2022
Page No : 256-259
Background: Global pandemic started in early December 2019 from Wuhan, China and this didn’t spare any part of the world. Millions of deaths have been reported and the disease treatment has been itself challenging due to varied clinical presentation. Hence, we studied to know the clinical characteristics and comorbidities associated withSARS-CoV-2.
Materials and Methods: Observational study was conducted during period of May 2020 to July 2020 on patients diagnosed positive for SARS-CoV-2 on RT-PCR method. Study was don’t know the clinical characteristics, comorbidities and outcome of the patients.
Results: Our study found out of 640 patients admitted, 70.31% were males while females were 29.68% and mostly affected were age group of 30-39 age (26.4%). Fever was observed most commonly in our study group. 77.34% patients didn’t have any coexisting comorbidity in the admitted cases; Hypertension was most common among the admitted cases. We found mortality in 12.66% cases and concomitant diabetes and hypertension was leading comorbidity in the deaths of SARS-CoV-2.
Conclusion: COVID 19 has spread like wildfire globally since first reported in Wuhan, China. It has a wide spectrum of clinical presentation with no particular signs and symptoms pinpointing the diagnosis. Appropriate investigations with quicker results are needed to achieve the same.
Keywords: COVID19, SARS, Pandemic